Alteration of p53-binding protein 1 expression during skin carcinogenesis: Association with genomic instability

Cancer Science

Volumn 99, Issue 5, 2008, Pages 946-951

  Naruke, Yuki ^a   Nakashima, Masahiro ^a   Suzuki, Keiji ^a   Matsuu matsuyama, Mutsumi ^a   Shichijo, Kazuko ^a   Kondo, Hisayoshi ^a   Sekine, Ichiro ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

P53 BINDING PROTEIN 1; PROTEIN P53; SIGNAL PEPTIDE; TP53BP1 PROTEIN, HUMAN;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBORRHEIC KERATOSIS; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; CELL NUCLEUS; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; EPIDERMIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENOMIC INSTABILITY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 43649095626     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00786.x     Document Type: Article

References (27)

1. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-9.
2. Coleman WB, Tsongalis GJ. The role of genomic instability in human carcinogenesis. Anticancer Res 1999; 19: 4645-64.
3. Miyazawa T, Sato H, Hatakeyama K, Kitagawa T, Kominami R. Allelic losses in mouse skin tumors induced by gamma-irradiation of p53 heterozygotes. Jpn J Cancer Res 2002; 93: 994-9.
4. Sadamori N, Mine M, Hori M. Skin cancer among atom bomb survivors. Lancet 1989; 1: 1267.
5. Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF, Koonin EV. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J 1997; 11: 68-76.
6. Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev 2002; 16: 583-93.
7. Ward IM, Minn K, Jorda KG, Chen J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J Biol Chem 2003; 278: 19579-82.
8. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 2000; 151: 1381-90.
9. Rappold I, Iwabuchi K, Date T, Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol 2001; 153: 613-20.
10. Anderson L, Henderson C, Adachi Y. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol Cell Biol 2001; 21: 1719-29.
11. Xia Z, Morales JC, Dunphy WG, Carpenter PB. Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1. J Biol Chem 2001; 276: 2708-18.
12. Shiloh Y, Kastan MBATM. genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 2001; 83: 209-54.
13. Xu Y, Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev 1996; 10: 2401-10.
14. Xu Y, Yang EM, Brugarolas J, Jacks T, Baltimore D. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice. Mol Cell Biol 1998; 18: 4385-90.
15. Mochan TA, Venere M, DiTullio RA Jr, Halazonetis TD. 53BP1 and NFBD1/ MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res 2003; 63: 8586-91.
16. Rakhorst HA, Tra WM, Posthumus-Van Sluijs ST et al. Quantitative analysis of radiation-induced DNA break repair in a cultured oral mucosal model. Tissue Eng 2006; 12: 3395-403.
17. Nakashima M, Suzuki K, Meirmanov S et al. Foci formation of p53-binding protein 1 in thyroid tumors: Activation of genomic instability during thyroid carcinogenesis. Int J Cancer 2008; 122: 1082-8.
18. Suzuki K, Yokoyama S, Waseda S, Kodama S, Watanabe M. Delayed reactivation of p53 in the progeny of cells surviving ionizing radiation. Cancer Res 2003; 63: 936-41.
19. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002; 2: 331-41.
20. Boukamp P. Non-melanoma skin cancer: What drives tumor development and progression? Carcinogenesis 2005; 26: 1657-67.
21. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992; 26: 467-84.
22. DiTullio RA Jr, Mochan TA, Venere M et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol 2002; 4: 998-1002.
23. Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum Mutat 2003; 21: 217-28.
24. Nakazawa H, English D, Randell PL et al. UV and skin cancer: Specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 1994; 91: 360-4.
25. Jonason AS, Kunala S, Price GJ et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996; 93: 14025-9.
26. Ling G, Persson A, Berne B, Uhlen M, Lundeberg J, Ponten F. Persistent p53 mutations in single cells from normal human skin. Am J Pathol 2001; 159: 1247-53.
27. Ren ZP, Ponten F, Nister M, Ponten J. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis. Int J Cancer 1996; 69: 174-9.